MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
F
F
Bauduer
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic; D005260:Female; D006526:Hepatitis C / Q000150:complications* / Q000276:immunology / Q000628:therapy; D006521:Hepatitis, Chronic / Q000150:complications* / Q000276:immunology / Q000628:therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000628:therapy; D009062:Mouth Neoplasms / Q000150:complications*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha